High potency with lower risk of off-target effects
DARPin Science
DARPins: Our class of multi-functional protein therapeutics with unique advantages
We have pioneered DARPin (Designed Ankyrin Repeat Protein) therapeutics, a new class of custom-built drugs based on natural binding proteins that open new dimensions of multi-functionality and multi-target specificity in drug design. The flexible architecture, intrinsic potential for high affinity and specificity, small size and high stability of DARPins offer benefits to drug design over other currently available protein-based therapeutics. DARPin therapeutics can be tailored to specific disease biology by leveraging key advantages of DARPins. DARPin therapeutics have been clinically validated across several therapeutic areas and developed through to the registrational stage.
By building on in-house expertise and leveraging partnerships with leaders in the field, Molecular Partners is continually unlocking and expanding the versatility of DARPin therapeutics for patients worldwide.
- Learn more about the DARPin platform and how we leverage DARPin properties for therapeutics
- Learn more about our programs & pipeline
-
High affinity and specificity
-
Multi-specificity
-
Small size (15 kDa)
-
Simple high-yield manufacturing
-
1 DARPin = 1 function
-
Long shelf-life and stability